Connect with us

Hi, what are you looking for?

Thursday, Mar 28, 2024
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.

Cannabis

Clever Leaves gets Brazilian GMP cannabis certification

The certification is mandatory for producing and commercializing cannabis products in the country

Clever Leaves gets Brazilian GMP certification for its cannabis
Image via Clever Leaves

The multinational cannabis producer Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) has obtained GMP certification from Brazilian authorities, enabling the company to supply cannabis to patients in the country.

The company announced the accomplishment on Tuesday having received the certification from ANVISA, the Brazilian Health Regulatory Agency.

Obtaining the GMP approval from Brazilian authorities marks the company’s fifth official international cannabis certification. Clever Leaves says it is the only cannabis company that is GMP-certified in Colombia, Brazil and the European Union.

“The awarding of Brazilian-GMP certification signifies a major milestone for Clever Leaves by further highlighting our commitment to producing high-quality and safe cannabis products that are trusted internationally and meet the highest regulatory standards,” said the company’s CEO Andres Fajardo, adding that the Brazilian market could potentially become the largest in Latin America and one of the biggest worldwide.

Similar to the stringent requirements of EU-GMP certification, ANVISA’s Brazilian-GMP certification is intended to prevent product contamination, reduce variations in compounds concentrations and prevent incorrect labelling among other things.

Currently, medical cannabis is legal in Brazil but adult-use or recreational pot is not.

Read more: Colombia includes medical cannabis in mandatory insurance coverage

Read more: Khiron opens its first Zerenia Clinic in Brazil

Clever leaves has 1.8 million square feet of cultivation space in Colombia, including an extraction facility capable of processing 104,400 kilograms of dried flower every year. The company says it is currently in the process of expanding to increase that capacity to 324,000 kilograms annually.

The company’s cannabis infrastructure in the European Union is headquartered in Germany where it runs a subsidiary called Clever Leaves Germany GmbH based in Hamburg.

Clever Leaves’ footprint spans across North America, Australia, New Zealand, Latin America, South Africa and other EU countries like the Czech Republic and Spain.

The company is involved with cultivation, extraction, genetics and cannabis research and development.

Clever Leaves shares dropped by 1.03 per cent Tuesday to US$0.25 on the Nasdaq Stock Exchange.

 

Follow Mugglehead on Twitter

Follow Rowan Dunne on Twitter

rowan@mugglehead.com

 

 

 

 

 

 

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Gold

Goldsource's Eagle Mountain project in Guyana is worth about US$292 million

Cannabis

The marijuana data firm Whitney Economics estimates that the United States will rake in US$2.6 billion more than last year

Lithium

The Hombre Muerto West project will start producing lithium chloride early next year

Lithium

The province's court made the decision following a lawsuit from the local Atacameños Indigenous group